Viveve Medical (VIVE) Shares Gap Up to $0.69
Shares of Viveve Medical Inc (NASDAQ:VIVE) gapped up prior to trading on Monday . The stock had previously closed at $0.76, but opened at $0.69. Viveve Medical shares last traded at $0.62, with a volume of 9096 shares.
A number of analysts recently weighed in on the stock. Maxim Group reaffirmed a “buy” rating on shares of Viveve Medical in a report on Thursday, January 17th. Mizuho reissued a “buy” rating and set a $4.00 target price on shares of Viveve Medical in a research note on Friday, March 15th. Finally, Craig Hallum set a $1.00 target price on shares of Viveve Medical and gave the company a “hold” rating in a research note on Friday, January 18th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $4.00.
The company has a current ratio of 3.89, a quick ratio of 3.51 and a debt-to-equity ratio of 6.21. The stock has a market cap of $26.84 million, a price-to-earnings ratio of -0.38 and a beta of 0.70.
ILLEGAL ACTIVITY WARNING: “Viveve Medical (VIVE) Shares Gap Up to $0.69” was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://theolympiareport.com/2019/04/15/viveve-medical-vive-shares-gap-up-to-0-69.html.
About Viveve Medical (NASDAQ:VIVE)
Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories.
Further Reading: What is the Coverage Ratio?
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.